Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
123.73B | 121.57B | 121.43B | 116.39B | 103.56B | Gross Profit |
86.70B | 84.81B | 83.21B | 77.94B | 70.44B | EBIT |
23.30B | 23.31B | 22.08B | 20.82B | 17.49B | EBITDA |
29.34B | 38.90B | 36.45B | 34.62B | 30.59B | Net Income Common Stockholders |
16.19B | 15.39B | 5.37B | 14.16B | 10.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.32B | 6.21B | 4.75B | 8.71B | 11.74B | Total Assets |
266.21B | 264.81B | 257.27B | 275.90B | 273.87B | Total Debt |
99.09B | 97.09B | 94.81B | 94.85B | 103.76B | Net Debt |
91.77B | 90.88B | 90.06B | 86.14B | 92.02B | Total Liabilities |
179.94B | 181.34B | 175.24B | 177.90B | 180.85B | Stockholders Equity |
85.56B | 82.70B | 80.94B | 96.09B | 90.32B |
Cash Flow | Free Cash Flow | |||
15.49B | 12.96B | 12.65B | 17.09B | 13.10B | Operating Cash Flow |
27.67B | 28.50B | 26.41B | 29.15B | 24.74B | Investing Cash Flow |
-15.67B | -7.16B | -14.14B | -13.45B | -12.05B | Financing Cash Flow |
-10.88B | -19.85B | -16.18B | -18.62B | -6.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $25.29B | 11.57 | 19.01% | 0.99% | 4.29% | 177.70% | |
77 Outperform | $134.23B | 8.57 | 18.92% | 3.45% | 1.78% | 11.62% | |
76 Outperform | $188.21B | 17.58 | 9.26% | 4.00% | -0.08% | -24.48% | |
74 Outperform | $58.37B | 10.47 | 38.11% | ― | 0.88% | 16.44% | |
73 Outperform | $181.44B | 10.40 | -224.44% | 6.12% | 0.61% | 50.39% | |
59 Neutral | $30.54B | 0.25 | -13.23% | 4.04% | 2.36% | -49.53% |